Lupin Limited has informed the Exchange regarding a press release dated October 23, 2023, titled "Lupin Receives Approval from U.S. FDA for Fluconazole Tablets, USP.".
Lupin Limited has informed the Exchange regarding a press release dated October 23, 2023, titled "Lupin Receives Approval from U.S. FDA for Fluconazole Tablets, USP.".